α4β7 integrin inhibitor programme

About C4X Discovery

C4X Discovery is a pioneering, publicly traded biotech using its Conformetrix® and PatientSeek platforms to accelerate and de-risk small molecule drug discovery, primarily in immuno-inflammation. The company has a mixed business model, advancing an internal pre-clinical pipeline while generating revenue through partnerships with major pharma like AstraZeneca and Sanofi. With a seasoned leadership team and a focus on precision targeting, C4XD aims to deliver higher-probability drug candidates by designing for specific patient populations.

Therapeutic Areas

Other Immuno-inflammatory diseases Drugs